Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway. [electronic resource]
Producer: 20180723Description: 1563-1573 p. digitalISSN:- 1791-2423
- Animals
- Apoptosis -- drug effects
- Carcinoma -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Drugs, Chinese Herbal -- administration & dosage
- Epithelial-Mesenchymal Transition -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- MicroRNAs -- genetics
- Neoplasm Invasiveness -- genetics
- Neoplasm Metastasis
- Stomach Neoplasms -- drug therapy
- Wnt Signaling Pathway -- drug effects
- Xenograft Model Antitumor Assays
- beta Catenin -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.